Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0199 Transporter Info | ||||
Gene Name | SLC25A37 | ||||
Transporter Name | Mitochondrial iron transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Bladder cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A37 in bladder cancer | [ 1 ] | |||
Location |
TSS1500 (cg14755852) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.51E+00 | Statistic Test | p-value:3.10E-04; Z-score:-3.44E+00 | ||
Methylation in Case |
7.57E-02 (Median) | Methylation in Control | 1.14E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A37 in bladder cancer | [ 1 ] | |||
Location |
TSS1500 (cg09621438) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.67E+00 | Statistic Test | p-value:7.75E-04; Z-score:-5.35E+00 | ||
Methylation in Case |
9.24E-02 (Median) | Methylation in Control | 1.54E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A37 in bladder cancer | [ 1 ] | |||
Location |
1stExon (cg25944700) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:1.42E-02; Z-score:-1.52E+00 | ||
Methylation in Case |
3.68E-02 (Median) | Methylation in Control | 4.62E-02 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A37 in bladder cancer | [ 1 ] | |||
Location |
Body (cg03084648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.11E+00 | Statistic Test | p-value:2.90E-04; Z-score:-4.69E+00 | ||
Methylation in Case |
6.92E-01 (Median) | Methylation in Control | 7.65E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A37 in bladder cancer | [ 1 ] | |||
Location |
Body (cg18186478) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.42E+00 | Statistic Test | p-value:7.59E-04; Z-score:-3.64E+00 | ||
Methylation in Case |
5.24E-01 (Median) | Methylation in Control | 7.42E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A37 in bladder cancer | [ 1 ] | |||
Location |
Body (cg24917065) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:4.98E-03; Z-score:2.72E+00 | ||
Methylation in Case |
5.61E-01 (Median) | Methylation in Control | 4.65E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A37 in bladder cancer | [ 1 ] | |||
Location |
Body (cg02190353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.61E+00 | Statistic Test | p-value:1.49E-02; Z-score:-2.62E+00 | ||
Methylation in Case |
2.72E-01 (Median) | Methylation in Control | 4.38E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A37 in bladder cancer | [ 1 ] | |||
Location |
Body (cg00892891) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:2.38E-02; Z-score:-1.66E+00 | ||
Methylation in Case |
8.08E-01 (Median) | Methylation in Control | 8.46E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A37 in bladder cancer | [ 1 ] | |||
Location |
Body (cg16812174) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.12E+00 | Statistic Test | p-value:2.46E-02; Z-score:-2.14E+00 | ||
Methylation in Case |
7.01E-01 (Median) | Methylation in Control | 7.87E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC25A37 in bladder cancer | [ 1 ] | |||
Location |
Body (cg18065686) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:3.64E-02; Z-score:1.02E+00 | ||
Methylation in Case |
9.00E-01 (Median) | Methylation in Control | 8.60E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A37 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg01770362) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.35E+00 | Statistic Test | p-value:6.33E-23; Z-score:3.48E+00 | ||
Methylation in Case |
6.15E-01 (Median) | Methylation in Control | 4.56E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A37 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg11051899) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.94E-07; Z-score:1.09E+00 | ||
Methylation in Case |
8.29E-01 (Median) | Methylation in Control | 7.78E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A37 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg09621438) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:7.04E-05; Z-score:6.61E-01 | ||
Methylation in Case |
1.18E-01 (Median) | Methylation in Control | 9.85E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A37 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg14755852) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:8.17E-05; Z-score:1.20E+00 | ||
Methylation in Case |
1.24E-01 (Median) | Methylation in Control | 1.06E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A37 in breast cancer | [ 2 ] | |||
Location |
Body (cg07659624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:7.18E-07; Z-score:1.59E+00 | ||
Methylation in Case |
7.03E-01 (Median) | Methylation in Control | 6.20E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A37 in breast cancer | [ 2 ] | |||
Location |
Body (cg02190353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.30E+00 | Statistic Test | p-value:1.18E-06; Z-score:1.14E+00 | ||
Methylation in Case |
5.25E-01 (Median) | Methylation in Control | 4.04E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A37 in breast cancer | [ 2 ] | |||
Location |
Body (cg03084648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:1.84E-04; Z-score:-1.23E+00 | ||
Methylation in Case |
7.36E-01 (Median) | Methylation in Control | 7.86E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A37 in breast cancer | [ 2 ] | |||
Location |
Body (cg00669044) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:2.14E-03; Z-score:-1.19E+00 | ||
Methylation in Case |
8.90E-01 (Median) | Methylation in Control | 9.28E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A37 in breast cancer | [ 2 ] | |||
Location |
Body (cg16812174) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:3.98E-03; Z-score:1.08E+00 | ||
Methylation in Case |
8.28E-01 (Median) | Methylation in Control | 7.59E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC25A37 in breast cancer | [ 2 ] | |||
Location |
Body (cg20890157) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.23E+00 | Statistic Test | p-value:4.41E-02; Z-score:6.39E-01 | ||
Methylation in Case |
6.50E-02 (Median) | Methylation in Control | 5.27E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A37 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS1500 (cg01770362) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.25E+00 | Statistic Test | p-value:1.17E-08; Z-score:2.26E+00 | ||
Methylation in Case |
6.59E-01 (Median) | Methylation in Control | 5.29E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A37 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS200 (cg17522466) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:2.03E-02; Z-score:5.06E-01 | ||
Methylation in Case |
1.88E-02 (Median) | Methylation in Control | 1.74E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A37 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
1stExon (cg25944700) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:8.82E-03; Z-score:6.07E-01 | ||
Methylation in Case |
1.17E-02 (Median) | Methylation in Control | 1.04E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A37 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg20890157) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+00 | Statistic Test | p-value:1.73E-03; Z-score:8.66E-01 | ||
Methylation in Case |
3.77E-02 (Median) | Methylation in Control | 2.97E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A37 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg03084648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:7.87E-03; Z-score:-1.14E+00 | ||
Methylation in Case |
8.80E-01 (Median) | Methylation in Control | 8.99E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A37 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg20207276) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.14E+00 | Statistic Test | p-value:1.54E-02; Z-score:2.51E+00 | ||
Methylation in Case |
8.98E-01 (Median) | Methylation in Control | 7.85E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A37 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg09621438) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:1.79E-07; Z-score:-1.71E+00 | ||
Methylation in Case |
2.08E-01 (Median) | Methylation in Control | 2.61E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A37 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg11051899) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.86E-02; Z-score:-4.81E-01 | ||
Methylation in Case |
8.97E-01 (Median) | Methylation in Control | 9.12E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A37 in colorectal cancer | [ 4 ] | |||
Location |
1stExon (cg20763254) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:2.44E-02; Z-score:2.60E-01 | ||
Methylation in Case |
9.60E-03 (Median) | Methylation in Control | 8.59E-03 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A37 in colorectal cancer | [ 4 ] | |||
Location |
1stExon (cg25944700) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:4.11E-02; Z-score:7.34E-01 | ||
Methylation in Case |
5.84E-02 (Median) | Methylation in Control | 5.03E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A37 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg03084648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:2.30E-05; Z-score:-1.35E+00 | ||
Methylation in Case |
8.55E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A37 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg07659624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:7.09E-05; Z-score:-1.01E+00 | ||
Methylation in Case |
9.04E-01 (Median) | Methylation in Control | 9.32E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A37 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg26801445) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:4.06E-04; Z-score:-1.14E+00 | ||
Methylation in Case |
9.12E-01 (Median) | Methylation in Control | 9.27E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A37 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg20207276) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:1.49E-03; Z-score:1.40E+00 | ||
Methylation in Case |
8.67E-01 (Median) | Methylation in Control | 7.17E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A37 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg02190353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:4.49E-03; Z-score:-7.51E-01 | ||
Methylation in Case |
4.57E-01 (Median) | Methylation in Control | 5.51E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg11051899) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:5.06E-05; Z-score:7.78E-01 | ||
Methylation in Case |
8.37E-01 (Median) | Methylation in Control | 8.15E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg14755852) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:5.25E-03; Z-score:-7.01E-01 | ||
Methylation in Case |
1.35E-01 (Median) | Methylation in Control | 1.54E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg01770362) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:1.95E-02; Z-score:8.07E-01 | ||
Methylation in Case |
6.72E-01 (Median) | Methylation in Control | 6.34E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg04927695) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.53E+00 | Statistic Test | p-value:6.76E-19; Z-score:-6.26E+00 | ||
Methylation in Case |
4.43E-01 (Median) | Methylation in Control | 6.77E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg06972578) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.51E+00 | Statistic Test | p-value:1.09E-12; Z-score:-4.50E+00 | ||
Methylation in Case |
4.35E-01 (Median) | Methylation in Control | 6.58E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg15704872) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.77E+00 | Statistic Test | p-value:7.75E-11; Z-score:-2.23E+00 | ||
Methylation in Case |
2.00E-01 (Median) | Methylation in Control | 3.53E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg03084648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:5.97E-05; Z-score:-9.61E-01 | ||
Methylation in Case |
7.49E-01 (Median) | Methylation in Control | 7.78E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg20207276) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:8.47E-04; Z-score:1.05E+00 | ||
Methylation in Case |
7.86E-01 (Median) | Methylation in Control | 7.26E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg00892891) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.10E-03; Z-score:-6.03E-01 | ||
Methylation in Case |
8.73E-01 (Median) | Methylation in Control | 8.88E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg02190353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:1.19E-03; Z-score:-7.49E-01 | ||
Methylation in Case |
6.67E-01 (Median) | Methylation in Control | 7.19E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg07659624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:1.42E-02; Z-score:9.38E-01 | ||
Methylation in Case |
7.98E-01 (Median) | Methylation in Control | 7.67E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg16812174) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.77E-02; Z-score:-3.52E-01 | ||
Methylation in Case |
8.91E-01 (Median) | Methylation in Control | 8.97E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC25A37 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg20890157) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:4.57E-02; Z-score:2.79E-01 | ||
Methylation in Case |
8.84E-02 (Median) | Methylation in Control | 8.04E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A37 in lung adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg01770362) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:2.15E-02; Z-score:1.18E+00 | ||
Methylation in Case |
6.34E-01 (Median) | Methylation in Control | 5.66E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A37 in lung adenocarcinoma | [ 6 ] | |||
Location |
1stExon (cg25944700) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:3.64E-02; Z-score:1.29E+00 | ||
Methylation in Case |
6.02E-02 (Median) | Methylation in Control | 5.50E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A37 in lung adenocarcinoma | [ 6 ] | |||
Location |
Body (cg02190353) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.74E+00 | Statistic Test | p-value:5.53E-04; Z-score:5.26E+00 | ||
Methylation in Case |
6.15E-01 (Median) | Methylation in Control | 3.53E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A37 in lung adenocarcinoma | [ 6 ] | |||
Location |
Body (cg18065686) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:8.41E-04; Z-score:1.57E+00 | ||
Methylation in Case |
8.56E-01 (Median) | Methylation in Control | 8.12E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A37 in lung adenocarcinoma | [ 6 ] | |||
Location |
Body (cg03084648) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:3.11E-03; Z-score:-1.96E+00 | ||
Methylation in Case |
7.93E-01 (Median) | Methylation in Control | 8.34E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A37 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg06375292) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:5.74E-18; Z-score:-2.47E+00 | ||
Methylation in Case |
5.52E-01 (Median) | Methylation in Control | 6.58E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A37 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg04344565) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.74E+00 | Statistic Test | p-value:1.59E-13; Z-score:2.88E+00 | ||
Methylation in Case |
4.39E-01 (Median) | Methylation in Control | 1.60E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A37 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg02322908) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.91E+00 | Statistic Test | p-value:2.31E-06; Z-score:-1.61E+00 | ||
Methylation in Case |
1.59E-01 (Median) | Methylation in Control | 3.04E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A37 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg18250838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:2.16E-04; Z-score:5.66E-01 | ||
Methylation in Case |
2.21E-01 (Median) | Methylation in Control | 1.85E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A37 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg19215261) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:2.11E-02; Z-score:4.01E-01 | ||
Methylation in Case |
9.17E-01 (Median) | Methylation in Control | 9.12E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A37 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg17298269) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.52E+00 | Statistic Test | p-value:1.83E-14; Z-score:-2.57E+00 | ||
Methylation in Case |
1.80E-01 (Median) | Methylation in Control | 2.73E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A37 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg22988581) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:3.90E-02; Z-score:6.73E-01 | ||
Methylation in Case |
4.53E-01 (Median) | Methylation in Control | 3.92E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A37 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg24856673) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+00 | Statistic Test | p-value:3.56E-07; Z-score:1.47E+00 | ||
Methylation in Case |
4.53E-01 (Median) | Methylation in Control | 3.57E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A37 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg15930240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:4.85E-07; Z-score:-1.07E+00 | ||
Methylation in Case |
7.10E-01 (Median) | Methylation in Control | 7.50E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC25A37 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
3'UTR (cg09292202) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.14E+00 | Statistic Test | p-value:6.79E-04; Z-score:9.24E-01 | ||
Methylation in Case |
7.50E-01 (Median) | Methylation in Control | 6.57E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC25A37 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
3'UTR (cg05627826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:4.44E-02; Z-score:6.75E-01 | ||
Methylation in Case |
7.87E-01 (Median) | Methylation in Control | 7.60E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A37 in panic disorder | [ 8 ] | |||
Location |
TSS1500 (cg11051899) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:1.50E-02; Z-score:4.84E-01 | ||
Methylation in Case |
3.34E+00 (Median) | Methylation in Control | 3.16E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A37 in panic disorder | [ 8 ] | |||
Location |
1stExon (cg25944700) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:9.81E-01 | Statistic Test | p-value:3.14E-04; Z-score:4.12E-01 | ||
Methylation in Case |
-5.60E+00 (Median) | Methylation in Control | -5.70E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A37 in panic disorder | [ 8 ] | |||
Location |
Body (cg00669044) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:2.02E-02; Z-score:3.85E-01 | ||
Methylation in Case |
2.39E+00 (Median) | Methylation in Control | 2.25E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A37 in panic disorder | [ 8 ] | |||
Location |
Body (cg26801445) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:4.74E-02; Z-score:3.07E-01 | ||
Methylation in Case |
3.23E+00 (Median) | Methylation in Control | 3.16E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A37 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg01770362) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:2.79E-04; Z-score:1.23E+00 | ||
Methylation in Case |
5.27E-01 (Median) | Methylation in Control | 4.49E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A37 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg11051899) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:5.63E-04; Z-score:2.08E+00 | ||
Methylation in Case |
8.92E-01 (Median) | Methylation in Control | 8.05E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A37 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg14755852) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.34E+00 | Statistic Test | p-value:7.12E-04; Z-score:-1.35E+00 | ||
Methylation in Case |
1.04E-01 (Median) | Methylation in Control | 1.39E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A37 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg09621438) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.44E+00 | Statistic Test | p-value:1.30E-02; Z-score:-1.05E+00 | ||
Methylation in Case |
1.16E-01 (Median) | Methylation in Control | 1.68E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A37 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg20890157) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.21E+00 | Statistic Test | p-value:1.25E-05; Z-score:-9.51E-01 | ||
Methylation in Case |
7.57E-02 (Median) | Methylation in Control | 9.17E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A37 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg16812174) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:5.90E-04; Z-score:9.04E-01 | ||
Methylation in Case |
9.39E-01 (Median) | Methylation in Control | 9.17E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC25A37 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg18186478) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:1.11E-03; Z-score:8.91E-01 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 7.80E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC25A37 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg18065686) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:1.76E-03; Z-score:9.85E-01 | ||
Methylation in Case |
9.34E-01 (Median) | Methylation in Control | 9.21E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC25A37 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg26801445) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.21E-03; Z-score:-1.95E-01 | ||
Methylation in Case |
8.36E-01 (Median) | Methylation in Control | 8.44E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A37 in prostate cancer | [ 10 ] | |||
Location |
TSS1500 (cg02701825) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.47E+00 | Statistic Test | p-value:2.85E-03; Z-score:2.21E+01 | ||
Methylation in Case |
5.62E-01 (Median) | Methylation in Control | 1.62E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC25A37 in colon adenocarcinoma | [ 11 ] | |||
Location |
TSS200 (cg16600501) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:1.31E-03; Z-score:-2.37E+00 | ||
Methylation in Case |
8.70E-01 (Median) | Methylation in Control | 9.18E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC25A37 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg14381448) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.25E+00 | Statistic Test | p-value:1.99E-07; Z-score:-2.73E+00 | ||
Methylation in Case |
5.55E-01 (Median) | Methylation in Control | 6.96E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC25A37 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg09660365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:3.10E-04; Z-score:1.02E+00 | ||
Methylation in Case |
5.38E-01 (Median) | Methylation in Control | 4.68E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC25A37 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg00967552) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.23E+00 | Statistic Test | p-value:1.20E-03; Z-score:1.62E+00 | ||
Methylation in Case |
3.28E-01 (Median) | Methylation in Control | 2.66E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC25A37 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg15266604) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:2.27E-03; Z-score:-1.74E+00 | ||
Methylation in Case |
8.17E-01 (Median) | Methylation in Control | 8.48E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC25A37 in colon adenocarcinoma | [ 11 ] | |||
Location |
3'UTR (cg18150383) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:2.99E-03; Z-score:-2.24E+00 | ||
Methylation in Case |
7.63E-01 (Median) | Methylation in Control | 8.15E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
55 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-150 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-150 | miRNA Mature ID | miR-150-5p | ||
miRNA Sequence |
UCUCCCAACCCUUGUACCAGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon2 |
miR-17 directly targets SLC25A37 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-17 | miRNA Mature ID | miR-17-5p | ||
miRNA Sequence |
CAAAGUGCUUACAGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon3 |
miR-181a directly targets SLC25A37 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-181a | miRNA Mature ID | miR-181a-5p | ||
miRNA Sequence |
AACAUUCAACGCUGUCGGUGAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon4 |
miR-181b directly targets SLC25A37 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-181b | miRNA Mature ID | miR-181b-5p | ||
miRNA Sequence |
AACAUUCAUUGCUGUCGGUGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon5 |
miR-181c directly targets SLC25A37 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-181c | miRNA Mature ID | miR-181c-5p | ||
miRNA Sequence |
AACAUUCAACCUGUCGGUGAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon6 |
miR-181d directly targets SLC25A37 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-181d | miRNA Mature ID | miR-181d-5p | ||
miRNA Sequence |
AACAUUCAUUGUUGUCGGUGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon7 |
miR-18a directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-18a | miRNA Mature ID | miR-18a-5p | ||
miRNA Sequence |
UAAGGUGCAUCUAGUGCAGAUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon8 |
miR-18b directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-18b | miRNA Mature ID | miR-18b-5p | ||
miRNA Sequence |
UAAGGUGCAUCUAGUGCAGUUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon9 |
miR-1976 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1976 | miRNA Mature ID | miR-1976 | ||
miRNA Sequence |
CCUCCUGCCCUCCUUGCUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon10 |
miR-2681 directly targets SLC25A37 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-2681 | miRNA Mature ID | miR-2681-5p | ||
miRNA Sequence |
GUUUUACCACCUCCAGGAGACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
miR-30a directly targets SLC25A37 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-30a | miRNA Mature ID | miR-30a-3p | ||
miRNA Sequence |
CUUUCAGUCGGAUGUUUGCAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
miR-30d directly targets SLC25A37 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-30d | miRNA Mature ID | miR-30d-3p | ||
miRNA Sequence |
CUUUCAGUCAGAUGUUUGCUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
miR-30e directly targets SLC25A37 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-30e | miRNA Mature ID | miR-30e-3p | ||
miRNA Sequence |
CUUUCAGUCGGAUGUUUACAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
miR-3144 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3144 | miRNA Mature ID | miR-3144-5p | ||
miRNA Sequence |
AGGGGACCAAAGAGAUAUAUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon15 |
miR-3191 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3191 | miRNA Mature ID | miR-3191-3p | ||
miRNA Sequence |
UGGGGACGUAGCUGGCCAGACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon16 |
miR-3606 directly targets SLC25A37 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3606 | miRNA Mature ID | miR-3606-3p | ||
miRNA Sequence |
AAAAUUUCUUUCACUACUUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon17 |
miR-3617 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3617 | miRNA Mature ID | miR-3617-5p | ||
miRNA Sequence |
AAAGACAUAGUUGCAAGAUGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon18 |
miR-365a directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-365a | miRNA Mature ID | miR-365a-5p | ||
miRNA Sequence |
AGGGACUUUUGGGGGCAGAUGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon19 |
miR-365b directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-365b | miRNA Mature ID | miR-365b-5p | ||
miRNA Sequence |
AGGGACUUUCAGGGGCAGCUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon20 |
miR-4279 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4279 | miRNA Mature ID | miR-4279 | ||
miRNA Sequence |
CUCUCCUCCCGGCUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon21 |
miR-4443 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4443 | miRNA Mature ID | miR-4443 | ||
miRNA Sequence |
UUGGAGGCGUGGGUUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon22 |
miR-4476 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4476 | miRNA Mature ID | miR-4476 | ||
miRNA Sequence |
CAGGAAGGAUUUAGGGACAGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon23 |
miR-452 directly targets SLC25A37 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-452 | miRNA Mature ID | miR-452-5p | ||
miRNA Sequence |
AACUGUUUGCAGAGGAAACUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon24 |
miR-4652 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4652 | miRNA Mature ID | miR-4652-5p | ||
miRNA Sequence |
AGGGGACUGGUUAAUAGAACUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon25 |
miR-4676 directly targets SLC25A37 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4676 | miRNA Mature ID | miR-4676-3p | ||
miRNA Sequence |
CACUGUUUCACCACUGGCUCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon26 |
miR-4693 directly targets SLC25A37 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4693 | miRNA Mature ID | miR-4693-5p | ||
miRNA Sequence |
AUACUGUGAAUUUCACUGUCACA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon27 |
miR-4704 directly targets SLC25A37 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4704 | miRNA Mature ID | miR-4704-3p | ||
miRNA Sequence |
UCAGUCACAUAUCUAGUGUCUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Left ventricular cardiac tissues of human | ||||
Epigenetic Phenomenon28 |
miR-4722 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4722 | miRNA Mature ID | miR-4722-3p | ||
miRNA Sequence |
ACCUGCCAGCACCUCCCUGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon29 |
miR-4735 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4735 | miRNA Mature ID | miR-4735-3p | ||
miRNA Sequence |
AAAGGUGCUCAAAUUAGACAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon30 |
miR-5089 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-5089 | miRNA Mature ID | miR-5089-5p | ||
miRNA Sequence |
GUGGGAUUUCUGAGUAGCAUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon31 |
miR-513a directly targets SLC25A37 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-513a | miRNA Mature ID | miR-513a-3p | ||
miRNA Sequence |
UAAAUUUCACCUUUCUGAGAAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon32 |
miR-513c directly targets SLC25A37 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-513c | miRNA Mature ID | miR-513c-3p | ||
miRNA Sequence |
UAAAUUUCACCUUUCUGAGAAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon33 |
miR-552 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-552 | miRNA Mature ID | miR-552-3p | ||
miRNA Sequence |
AACAGGUGACUGGUUAGACAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon34 |
miR-5571 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-5571 | miRNA Mature ID | miR-5571-5p | ||
miRNA Sequence |
CAAUUCUCAAAGGAGCCUCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon35 |
miR-582 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-582 | miRNA Mature ID | miR-582-3p | ||
miRNA Sequence |
UAACUGGUUGAACAACUGAACC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon36 |
miR-619 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-619 | miRNA Mature ID | miR-619-5p | ||
miRNA Sequence |
GCUGGGAUUACAGGCAUGAGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon37 |
miR-636 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-636 | miRNA Mature ID | miR-636 | ||
miRNA Sequence |
UGUGCUUGCUCGUCCCGCCCGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon38 |
miR-641 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-641 | miRNA Mature ID | miR-641 | ||
miRNA Sequence |
AAAGACAUAGGAUAGAGUCACCUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon39 |
miR-6504 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6504 | miRNA Mature ID | miR-6504-3p | ||
miRNA Sequence |
CAUUACAGCACAGCCAUUCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon40 |
miR-6505 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6505 | miRNA Mature ID | miR-6505-5p | ||
miRNA Sequence |
UUGGAAUAGGGGAUAUCUCAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon41 |
miR-6506 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6506 | miRNA Mature ID | miR-6506-5p | ||
miRNA Sequence |
ACUGGGAUGUCACUGAAUAUGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon42 |
miR-6515 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6515 | miRNA Mature ID | miR-6515-5p | ||
miRNA Sequence |
UUGGAGGGUGUGGAAGACAUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon43 |
miR-6727 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6727 | miRNA Mature ID | miR-6727-3p | ||
miRNA Sequence |
UCCUGCCACCUCCUCCGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon44 |
miR-6747 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6747 | miRNA Mature ID | miR-6747-3p | ||
miRNA Sequence |
UCCUGCCUUCCUCUGCACCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon45 |
miR-6778 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6778 | miRNA Mature ID | miR-6778-3p | ||
miRNA Sequence |
UGCCUCCCUGACAUUCCACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon46 |
miR-6810 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6810 | miRNA Mature ID | miR-6810-5p | ||
miRNA Sequence |
AUGGGGACAGGGAUCAGCAUGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon47 |
miR-6814 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6814 | miRNA Mature ID | miR-6814-5p | ||
miRNA Sequence |
UCCCAAGGGUGAGAUGCUGCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon48 |
miR-6876 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6876 | miRNA Mature ID | miR-6876-5p | ||
miRNA Sequence |
CAGGAAGGAGACAGGCAGUUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon49 |
miR-6894 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6894 | miRNA Mature ID | miR-6894-5p | ||
miRNA Sequence |
AGGAGGAUGGAGAGCUGGGCCAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon50 |
miR-7 directly targets SLC25A37 | [ 18 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Sequencing | ||
miRNA Stemloop ID |
miR-7 | miRNA Mature ID | miR-7-5p | ||
miRNA Sequence |
UGGAAGACUAGUGAUUUUGUUGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon51 |
miR-7151 directly targets SLC25A37 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-7151 | miRNA Mature ID | miR-7151-3p | ||
miRNA Sequence |
CUACAGGCUGGAAUGGGCUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon52 |
miR-7154 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-7154 | miRNA Mature ID | miR-7154-3p | ||
miRNA Sequence |
AGGAGGACAAGUUGUGGGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon53 |
miR-765 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-765 | miRNA Mature ID | miR-765 | ||
miRNA Sequence |
UGGAGGAGAAGGAAGGUGAUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon54 |
miR-766 directly targets SLC25A37 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-766 | miRNA Mature ID | miR-766-5p | ||
miRNA Sequence |
AGGAGGAAUUGGUGCUGGUCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon55 |
miR-892c directly targets SLC25A37 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-892c | miRNA Mature ID | miR-892c-3p | ||
miRNA Sequence |
CACUGUUUCCUUUCUGAGUGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Patient tissue samples | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.